IC
Ikarian Capital Portfolio holdings
AUM
$302M
This Quarter Return
-0.53%
1 Year Return
+65.21%
3 Year Return
+441.33%
5 Year Return
+548.26%
10 Year Return
–
AUM
$241M
AUM Growth
+$241M
(-27%)
Cap. Flow
-$44.4M
Cap. Flow
% of AUM
-18.42%
Top 10 Holdings %
Top 10 Hldgs %
47.34%
Holding
189
New
16
Increased
13
Reduced
42
Closed
72
Top Buys
| 1 |
Esperion Therapeutics
ESPR
|
$13.1M |
| 2 |
Altimmune
ALT
|
$10.5M |
| 3 |
United Therapeutics
UTHR
|
$9.43M |
| 4 |
Alnylam Pharmaceuticals
ALNY
|
$8.75M |
| 5 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
$6.33M |
Top Sells
| 1 |
BCYC
Bicycle Therapeutics
BCYC
|
$21M |
| 2 |
Zentalis Pharmaceuticals
ZNTL
|
$9.33M |
| 3 |
SAGE
Sage Therapeutics
SAGE
|
$8.27M |
| 4 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$7.11M |
| 5 |
SRRA
Sierra Oncology, Inc. Common Stock
SRRA
|
$6.98M |
Sector Composition
| 1 | Healthcare | 98.31% |
| 2 | Technology | 0.25% |
| 3 | Consumer Staples | 0.07% |
| 4 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Viking Therapeutics
VKTX
$3.02B
| $2.41M | 0.44% |
835,275
+302,846
| +57% | +$875K |
|
27
Cogent Biosciences
COGT
$1.83B
| $2.26M | 0.41% |
+250,000
| New | +$2.26M |
|
28
Adicet Bio
ACET
$60.8M
| $2.09M | 0.38% |
143,214
-364,134
| -72% | -$5.32M |
|
29
Lyra Therapeutics
LYRA
$11.8M
| $1.96M | 0.36% |
6,947
-1,500
| -18% | -$424K |
|
30
Apellis Pharmaceuticals
APLS
$3.51B
| $1.89M | 0.35% |
+41,900
| New | +$1.89M |
|
31
Sarepta Therapeutics
SRPT
$1.98B
| $1.87M | 0.34% |
+25,000
| New | +$1.87M |
|
32
Seres Therapeutics
MCRB
$162M
| $1.85M | 0.34% |
27,031
-15,000
| -36% | -$1.03M |
|
33
Astria Therapeutics
ATXS
$372M
| $1.78M | 0.32% |
592,123
+499,900
| +542% | +$1.5M |
|
34
Terns Pharmaceuticals
TERN
$651M
| $1.74M | 0.32% |
+700,000
| New | +$1.74M |
|
35
X4 Pharmaceuticals
XFOR
$70M
| $1.62M | 0.3% |
55,992
+10,258
| +22% | +$297K |
|
36
Aldeyra Therapeutics
ALDX
$350M
| $1.5M | 0.27% |
375,000
| – | – |
|
|
ICPT
37
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $1.45M | 0.26% |
105,000
+69,851
| +199% | +$964K |
|
|
DBVT
38
DBV Technologies
DBVT
$249M
| $1.4M | 0.26% |
31,694
| – | – |
|
39
Immatics
IMTX
$662M
| $1.37M | 0.25% |
157,190
-624,198
| -80% | -$5.44M |
|
|
NTBL
40
DELISTED
Notable Labs, Ltd. Ordinary Shares
NTBL
| $1.34M | 0.24% |
23,714
-22
| -0.1% | -$1.24K |
|
|
WHWK
41
Whitehawk Therapeutics, Inc. Common Stock
WHWK
$85.3M
| $1.27M | 0.23% |
412,343
+203,975
| +98% | +$630K |
|
42
Merus
MRUS
$5.04B
| $1.22M | 0.22% |
53,703
| – | – |
|
43
Cabaletta Bio
CABA
$144M
| $1M | 0.18% |
944,431
-75,639
| -7% | -$80.1K |
|
|
CMMB
44
Chemomab Therapeutics
CMMB
$15.7M
| $992K | 0.18% |
67,026
| – | – |
|
45
Ardelyx
ARDX
$1.57B
| $991K | 0.18% |
+1,680,552
| New | +$991K |
|
46
Anebulo Pharmaceuticals
ANEB
$101M
| $942K | 0.17% |
181,199
| – | – |
|
|
FNCH
47
DELISTED
Finch Therapeutics Group, Inc. Common Stock
FNCH
| $938K | 0.17% |
11,017
| – | – |
|
|
CMRX
48
DELISTED
Chimerix, Inc.
CMRX
| $917K | 0.17% |
441,203
-400,000
| -48% | -$831K |
|
|
AUTL
49
Autolus Therapeutics
AUTL
$383M
| $912K | 0.17% |
322,217
-50,000
| -13% | -$142K |
|
50
Eledon Pharmaceuticals
ELDN
$155M
| $884K | 0.16% |
362,537
| – | – |
|